3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Gastrointestinal Stromal Tumors
2
Colorectal Neoplasms
2
Biliary Tract Neoplasms
2
Advanced or Metastatic Solid Tumors
2
Thymoma
1
Solid Tumor
1
Sarcoma
1
Piebaldism
1
Osteosarcoma
1
Nasopharyngeal Carcinoma
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Advanced Solid Tumor
1
Advanced Renal Cell Carcinoma (aRCC)
1
Advanced Refractory Solid Tumors
1
Interventions
Oxaliplatin
27
Fluorouracil
23
Leucovorin
22
Cetuximab
22
Bevacizumab
21
Nivolumab
16
Capecitabine
16
Irinotecan
15
pembrolizumab
11
Magnetic Resonance Spectroscopy
11
Specimen Handling
10
encorafenib
8
Folfox protocol
7
trifluridine tipiracil drug combination
6
Ipilimumab
6
Exercise
6
fludarabine
5
cemiplimab
5
Trastuzumab
5
Gemcitabine
5
Cyclophosphamide
5
Cisplatin
5
Blood Specimen Collection
5
Biopsy
5
regorafenib
4
pertuzumab
4
adagrasib
4
Trifluridine
4
Pemetrexed
4
Immune Checkpoint Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
envafolimab
×
1 year
×
Clear all
No trials found.